Burford Brothers’s Teva Pharmaceuticals TEVA Stock Holding History

Burford Brothers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5M	Buy	147,536 +1,166	+0.8%	+$38.8K	1.83%	11
2026 Q1	$4.41M	Sell	146,370 -1,145	-0.8%	-$36.8K	1.81%	11
2025 Q4	$4.6M	Sell	147,515 -1,229	-0.8%	-$30.3K	1.9%	12
2025 Q3	$3M	Sell	148,744 -6,579	-4%	-$116K	1.28%	17
2025 Q2	$2.6M	Sell	155,323 -553	-0.4%	-$8.92K	1.19%	16
2025 Q1	$2.4M	Buy	155,876 +3,189	+2%	+$57K	1.16%	17
2024 Q4	$3.37M	Sell	152,687 -575	-0.4%	-$10.5K	1.65%	12
2024 Q3	$2.76M	Buy	153,262 +5,618	+4%	+$98.3K	1.44%	13
2024 Q2	$2.4M	Buy	147,644 +6,585	+5%	+$101K	1.39%	14
2024 Q1	$1.99M	Buy	141,059 +1,360	+1%	+$17.1K	1.31%	15
2023 Q4	$1.46M	Buy	+139,699	New	+$1.3M	1.03%	23

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Burford Brothers's TEVA Position: Q2 2026 in Review

Burford Brothers increased its Teva Pharmaceuticals (TEVA) stake by 0.8% in Q2 2026, buying an estimated $38.8K and bringing the position to 147,536 shares worth $5M. The position accounts for 1.83% of the portfolio, ranked #11.

Burford Brothers first reported a position in TEVA in Q4 2023 and has held it in 11 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Burford Brothers held 147,536 shares of Teva Pharmaceuticals worth $5M as of Q2 2026.
Burford Brothers bought 1,166 Teva Pharmaceuticals shares in Q2 2026, an estimated $38.8K.
Teva Pharmaceuticals made up 1.83% of Burford Brothers's portfolio in Q2 2026, its #11 holding.
Burford Brothers first reported a position in Teva Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
676 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Burford Brothers's 13F filing for Q2 2026, filed 28 Jul 2026.